Home Have synthetic antibodies been used for COVID 19?

      Have synthetic antibodies been used for COVID 19?

      Cardiology Image 1 Verified By April 30, 2020

      399
      COVID19-FAQ
      Fallback Image

      Clinical trials have commenced evaluating if gimsilumab, an artificially synthesized antibody can reduce death risk among patients with Covid-19.  Covid-19 patients develop an excessive immune response causing acute respiratory distress syndrome (ARDS) and death. Gimsilumab is a monoclonal antibody that attacks the granulocyte macrophage-colony stimulating factor (GM-CSF), a key driver of lung hyper-inflammation.

      Cardiology Image 1

      Related Articles

      More Articles

      Most Popular Articles

      More Articles
      © Copyright 2024. Apollo Hospitals Group. All Rights Reserved.
      Book ProHealth Book Appointment
      Request A Call Back X